Metabolomic Profiling and Drug Interaction Characterization Reveal Riboflavin As a Breast Cancer Resistance Protein–Specific Endogenous Biomarker That Demonstrates Prediction of Transporter Activity In VivoYueping Zhang, Hong Shen, Bethanne M. Warrack et al.|Drug Metabolism and Disposition|2023Cited by 15